Found: 21
Select item for more details and to access through your institution.
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.
- Published in:
- Human Reproduction, 2024, v. 39, n. 8, p. 1701, doi. 10.1093/humrep/deae112
- By:
- Publication type:
- Article
Interdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study.
- Published in:
- European Journal of Cancer Care, 2017, v. 26, n. 4, p. n/a, doi. 10.1111/ecc.12458
- By:
- Publication type:
- Article
Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interleukin-10 Directly Inhibits the Interleukin-6 Production in T-Cells.
- Published in:
- Scandinavian Journal of Immunology, 1995, v. 41, n. 5, p. 462, doi. 10.1111/j.1365-3083.1995.tb03593.x
- By:
- Publication type:
- Article
Activation of Protein Kinase C Induces De Novo Synthesis of the Soluble Interleukin-6 Receptor in Human B Cells.
- Published in:
- Scandinavian Journal of Immunology, 1994, v. 40, n. 5, p. 515, doi. 10.1111/j.1365-3083.1994.tb03498.x
- By:
- Publication type:
- Article
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 651, doi. 10.1038/bmt.2012.204
- By:
- Publication type:
- Article
Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 10, p. 1574, doi. 10.1002/pbc.24598
- By:
- Publication type:
- Article
Determination of terephthalic acid isopropylamide in urine with a liquid chromatography/mass spectrometry (LC/MS) method.
- Published in:
- Journal of Clinical Laboratory Analysis, 2008, v. 22, n. 1, p. 21, doi. 10.1002/jcla.20213
- By:
- Publication type:
- Article
DDAVP treatment in a child with von Willebrand disease type 2M.
- Published in:
- European Journal of Pediatrics, 1999, v. 158, n. 15, p. S174, doi. 10.1007/PL00014349
- By:
- Publication type:
- Article
DDAVP treatment in a child with von Willebrand disease type 2M.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH).
- Published in:
- 1999
- By:
- Publication type:
- journal article
Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
- Published in:
- Bone Marrow Transplantation, 2005, v. 35, n. 7, p. 691, doi. 10.1038/sj.bmt.1704874
- By:
- Publication type:
- Article
LUNG STAGING IN PEDIATRIC HODGKIN LYMPHOMA: STAGING EVALUATION & RESPONSE CRITERIA HARMONIZATION FOR CHILDHOOD, ADOLESCENT & YOUNG ADULT HL (SEARCH FOR CAYAHL) CONSENSUS.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 71, doi. 10.1002/hon.3163_37
- By:
- Publication type:
- Article
PHASE 2 KEYNOTE‐667: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT‐LINE CHEMOTHERAPY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 66, doi. 10.1002/hon.3163_31
- By:
- Publication type:
- Article
SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 55, doi. 10.1002/hon.25_2629
- By:
- Publication type:
- Article
RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 56, doi. 10.1002/hon.26_2629
- By:
- Publication type:
- Article
INCLUSION OF A PEDIATRIC PERSPECTIVE INTO RECOMMENDATIONS FOR THE INITIAL EVALUATION AND STAGING OF HODGKIN LYMPHOMA: A CALL TO ACTION FROM THE INTERNATIONAL SEARCH WORKING GROUP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 55, doi. 10.1002/hon.24_2629
- By:
- Publication type:
- Article
RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 56, doi. 10.1002/hon.26_2629
- By:
- Publication type:
- Article
SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 55, doi. 10.1002/hon.25_2629
- By:
- Publication type:
- Article
INCLUSION OF A PEDIATRIC PERSPECTIVE INTO RECOMMENDATIONS FOR THE INITIAL EVALUATION AND STAGING OF HODGKIN LYMPHOMA: A CALL TO ACTION FROM THE INTERNATIONAL SEARCH WORKING GROUP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 55, doi. 10.1002/hon.24_2629
- By:
- Publication type:
- Article
A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE-CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL).
- Published in:
- Hematological Oncology, 2017, v. 35, p. 248, doi. 10.1002/hon.2438_111
- By:
- Publication type:
- Article